Our new vascularPODCAST series is brought to you monthly in association with Medtronic. Each episode features an expert host that will bring you the most topical and relevant news items, conversations and commentaries on all things vascular, from across the globe to provide a truly international perspective.

vascularPODCAST by Radcliffe Vascular
Claim This Podcastby vascularPODCAST
Podcast Overview
Our new vascularPODCAST series is brought to you monthly in association with Medtronic. Each episode features an expert host that will bring you the most topical and relevant news items, conversations and commentaries on all things vascular, from across the globe to provide a truly international perspective.
Language
🇺🇲
Publishing Since
9/9/2020
1 verified contact email on file for vascularPODCAST by Radcliffe Vascular
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

August 13, 2021
EP 9: Vascular Surgery in a War Zone
This month guest host, Ramesh Tripathi, (University of Queensland, Au) meets with Dr Lt Dawn Coleman (University of Michigan, US) a clinical associate professor in vascular surgery, to discuss her experience as a general military surgeon in the US reserve army. Hear them discuss issues around wellness and burnout and in the US military and civilian life and her role in the Society of Vascular Surgery (SVS) wellness group. Learn what it's like to work under threat with mass casualties in small teams and understand what preparations are required. Hear how her background in vascular surgery benefited her deployment as a US reservist general surgeon and helped make her "a better general surgeon" and how her deployment experience taught her the importance of team communication, relationships and gratitude. They discuss treatment options in vascular-related injuries on the front line and how the use of tourniquets have become standard use in emergency field medicine.

May 28, 2021
EP 8: CLTI: Perspectives From The Lion City
Why is the Asian population so different and difficult to treat for BTK complications compared to their European counterparts? This month’s vascularPODCAST episode features guest host, Associate Professor Andrew Choong and panellists Associate Profs Tjung Tang and Edward Choke (Sengkang General Hospital, Singapore) to discuss chronic limb-threatening ischaemia (CLTI) with a focus on why ‘endovascular-first’ is the go-to treatment option in Singapore. They examine the latest trial data available to support treatment options and consider what the future holds for CLTI treatment and BTK vasculature. Hear them discuss: - The differences between treating patients for BTK: Asia vs Europe - Examination of available data: FUTURE-BTK and MERLION - The Paclitaxel safety controversy, including an examination of the Katsanos meta-analysis - Sirolimus as a future technology for SFA, popliteal disease and BTK - DBCs to treat BTK: which are appropriate? - The future for CLTI treatment options and BTK vasculature

April 23, 2021
EP 7: AAA: Appropriateness and Treatment Options Post-NICE
Should an aneurysm always be treated? Steven Black, MD, hosts this month’s episode and is joined by guests Prof Ian Loftus, Prof Bijan Modarai and Dr Jude Partridge to answer this question. Together they discuss the appropriateness of aortic aneurysm intervention, for the treatment of aortic disease. They consider the impact of the NICE guidelines and explore what’s important to the patient before selecting treatment options, considering factors such as QoL and highlight the need for patient-centred care. They examine the impact that COVID-19 has had on aortic services and debate whether it’s appropriate to increase the aneurysm threshold because of stretched services. An episode that attempts to move the conversation forwards and drive change; tune in to hear more on: - Selecting the right patients for aneurysm intervention - Cost-effectiveness, available technology and outcomes - RCTs: the importance of trial designs - Which intervention, which technology and considerations for safety - The appropriate outcome measures - Is there an appetite to change practice? - The future for AAA treatment and intervention Follow us on social media for the latest updates on the next episode @RadcliffeVASCU today! Produced by Radcliffe Vascular. Sponsored by Medtronic.
9 total episodes available
Deep-dive analytics for vascularPODCAST by Radcliffe Vascular
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is vascularPODCAST by Radcliffe Vascular?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.
